Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
CA 2326634 A1 · Owner: The Trustees Of Columbia University In The City Of New York · Inventors: Schmidt, Ann Marie; Stern, David; Rose, Eric
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention is a method for inhibiting thrombosis in a patient whose blood is subjected to extra-corporeal blood circulation which comprises contacting the extra-corporeal circulating blood with a Factor IXa compound in an amount effective to inhibit thrombosis in the patient. The patient may be subjected to extra-corporeal blood circulation during transplant surgery or cardiopulmonary bypass surgery or any surgery in which obligate clamping of a blood vessel is required. Further, a pharmaceutical composition includes an effective amount of a Factor IXa compound and a pharmaceutically acceptable , carrier.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 1, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 1, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 1, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.